Search research articles
Contact Us
Filters
Showing results (51-60 of 188) with videos related to
Page
of 19
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 7, 2020
Once-Weekly Subcutaneous Delivery of Polymer-Linked Rotigotine (SER-214) Provides Continuous Plasma Levels in Parkinson's Disease Patients
C Warren Olanow, David G Standaert, Karl Kieburtz, et al.
Neuroepidemiology
|
November 6, 2009
Racial differences in Parkinson's disease medication use in the reasons for geographic and racial differences in stroke cohort: a cross-sectional study
Talene A Yacoubian, George Howard, Brett Kissela, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 26, 2016
microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease
Aaron D Thome, Ashley S Harms, Laura A Volpicelli-Daley, et al.
Plos One
|
February 15, 2013
Angiogenin in Parkinson disease models: role of Akt phosphorylation and evaluation of AAV-mediated angiogenin expression in MPTP treated mice
Trent U Steidinger, Sunny R Slone, Huiping Ding, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 28, 2006
Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking
Penelope J Hallett, Robert Spoelgen, Bradley T Hyman, et al.
Neurobiology of Disease
|
October 24, 2009
VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's disease
Qingmin Ruan, Adam J Harrington, Kim A Caldwell, et al.
Journal of Neurochemistry
|
March 29, 2016
How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?
Laura A Volpicelli-Daley, Deniz Kirik, Lindsay E Stoyka, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
July 20, 2019
Diverse Mechanisms Lead to Common Dysfunction of Striatal Cholinergic Interneurons in Distinct Genetic Mouse Models of Dystonia
Karen L Eskow Jaunarajs, Mariangela Scarduzio, Michelle E Ehrlich, et al.
Plos One
|
September 24, 2010
Transduction of brain dopamine neurons by adenoviral vectors is modulated by CAR expression: rationale for tropism modified vectors in PD gene therapy
Travis B Lewis, Joel N Glasgow, Anya M Glandon, et al.
Viruses
|
September 9, 2014
Fiber-modified adenovirus for central nervous system Parkinson's disease gene therapy
Travis B Lewis, Joel N Glasgow, Ashley S Harms, et al.
Page
of 19
Search research articles
Search
Showing results (51-60 of 188) with videos related to
Sort By:
Page
of 19
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 7, 2020
Once-Weekly Subcutaneous Delivery of Polymer-Linked Rotigotine (SER-214) Provides Continuous Plasma Levels in Parkinson's Disease Patients
C Warren Olanow, David G Standaert, Karl Kieburtz, et al.
Neuroepidemiology
|
November 6, 2009
Racial differences in Parkinson's disease medication use in the reasons for geographic and racial differences in stroke cohort: a cross-sectional study
Talene A Yacoubian, George Howard, Brett Kissela, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 26, 2016
microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease
Aaron D Thome, Ashley S Harms, Laura A Volpicelli-Daley, et al.
Plos One
|
February 15, 2013
Angiogenin in Parkinson disease models: role of Akt phosphorylation and evaluation of AAV-mediated angiogenin expression in MPTP treated mice
Trent U Steidinger, Sunny R Slone, Huiping Ding, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 28, 2006
Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking
Penelope J Hallett, Robert Spoelgen, Bradley T Hyman, et al.
Neurobiology of Disease
|
October 24, 2009
VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's disease
Qingmin Ruan, Adam J Harrington, Kim A Caldwell, et al.
Journal of Neurochemistry
|
March 29, 2016
How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?
Laura A Volpicelli-Daley, Deniz Kirik, Lindsay E Stoyka, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
July 20, 2019
Diverse Mechanisms Lead to Common Dysfunction of Striatal Cholinergic Interneurons in Distinct Genetic Mouse Models of Dystonia
Karen L Eskow Jaunarajs, Mariangela Scarduzio, Michelle E Ehrlich, et al.
Plos One
|
September 24, 2010
Transduction of brain dopamine neurons by adenoviral vectors is modulated by CAR expression: rationale for tropism modified vectors in PD gene therapy
Travis B Lewis, Joel N Glasgow, Anya M Glandon, et al.
Viruses
|
September 9, 2014
Fiber-modified adenovirus for central nervous system Parkinson's disease gene therapy
Travis B Lewis, Joel N Glasgow, Ashley S Harms, et al.
Page
of 19